# American Well Corp: overview AMWL · NYSE · CIK 1393584 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/amwl.md) · [Financials](/companies/amwl/financials.md) · [Filings](/companies/amwl/filings.md) · [Insiders](/companies/amwl/insiders.md) Latest reported revenue: [$52.0m](/filings/0001393584-26-000018.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001393584-26-000018). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [61.0](/filings/0001193125-25-264718.md) | [71.0 d](/filings/0001193125-26-048776.md) | [66.8](/filings/0001393584-26-000013.md) | [70.9](/filings/0001393584-26-000018.md) | [56.3](/filings/0001193125-25-264718.md) | [55.3 d](/filings/0001193125-26-048776.md) | [54.9](/filings/0001393584-26-000013.md) | [52.0](/filings/0001393584-26-000018.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(77.6%)](/filings/0001193125-25-264718.md) | [(60.2%) d](/filings/0001193125-26-048776.md) | [(45.5%)](/filings/0001393584-26-000013.md) | [(28.7%)](/filings/0001393584-26-000018.md) | [(52.1%)](/filings/0001193125-25-264718.md) | [(45.5%) d](/filings/0001193125-26-048776.md) | [(31.7%)](/filings/0001393584-26-000013.md) | [(18.4%)](/filings/0001393584-26-000018.md) | | Net margin | % | [(71.2%)](/filings/0001193125-25-264718.md) | [(60.1%) d](/filings/0001193125-26-048776.md) | [(28.0%)](/filings/0001393584-26-000013.md) | [(27.8%)](/filings/0001393584-26-000018.md) | [(57.5%)](/filings/0001193125-25-264718.md) | [(45.1%) d](/filings/0001193125-26-048776.md) | [(19.8%)](/filings/0001393584-26-000013.md) | [(19.1%)](/filings/0001393584-26-000018.md) | | Diluted EPS | $ per share | [(2.87)](/filings/0001193125-25-264718.md) | not reported | [(1.19)](/filings/0001393584-26-000013.md) | [(1.24)](/filings/0001393584-26-000018.md) | [(2.00)](/filings/0001193125-25-264718.md) | not reported | [(0.66)](/filings/0001393584-26-000013.md) | [(0.59)](/filings/0001393584-26-000018.md) | | Free cash flow | $m | [(32.4) d](/filings/0001193125-25-264718.md) | [(13.4) d](/filings/0001193125-26-048776.md) | [(25.1)](/filings/0001393584-26-000013.md) | [(4.7) d](/filings/0001393584-26-000018.md) | [(18.8) d](/filings/0001193125-25-264718.md) | [(17.4) d](/filings/0001193125-26-048776.md) | [(1.0)](/filings/0001393584-26-000013.md) | [10.7 d](/filings/0001393584-26-000018.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [253](/filings/0000950170-24-024026.md) | [277](/filings/0000950170-25-019024.md) | [259](/filings/0001193125-26-048776.md) | [254](/filings/0001193125-26-048776.md) | [249](/filings/0001193125-26-048776.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(70.9%)](/filings/0000950170-24-024026.md) | [(99.5%)](/filings/0000950170-25-019024.md) | [(267.2%)](/filings/0001193125-26-048776.md) | [(85.5%)](/filings/0001193125-26-048776.md) | [(42.2%)](/filings/0001193125-26-048776.md) | | Net margin | % | [(69.8%)](/filings/0000950170-24-024026.md) | [(97.6%)](/filings/0000950170-25-019024.md) | [(260.6%)](/filings/0001193125-26-048776.md) | [(81.8%)](/filings/0001193125-26-048776.md) | [(38.4%)](/filings/0001193125-26-048776.md) | | Diluted EPS | $ per share | [(0.69)](/filings/0000950170-24-024026.md) | [(19.72)](/filings/0000950170-25-019024.md) | [(47.50)](/filings/0001193125-26-048776.md) | [(13.88)](/filings/0001193125-26-048776.md) | [(5.96)](/filings/0001193125-26-048776.md) | | Free cash flow | $m | [(142)](/filings/0000950170-24-024026.md) | [(193)](/filings/0000950170-25-019024.md) | [(149)](/filings/0001193125-26-048776.md) | [(127)](/filings/0001193125-26-048776.md) | [(66.0)](/filings/0001193125-26-048776.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/amwl/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Senvest Management, LLC](/funds/1328785.md) | 2026-06-30 | $12.1m | 1,329,057 | | Added +192,499 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $11.7m | 1,278,429 | | Added +121,976 | | [Cable Car Capital, LP](/funds/1699575.md) | 2026-06-30 | $9.1m | 1,002,650 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.6m | 611,259 | | Added +43,988 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.9m | 427,576 | | Added +36,197 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $2.4m | 263,223 | | Added +68,200 | | [Russell Investments Group, Ltd.](/funds/1692234.md) | 2026-06-30 | $1.7m | 182,243 | | New +182,243 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.4m | 158,623 | | Reduced −29,749 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $1.3m | 145,104 | | Added +12,095 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.3m | 141,282 | | Added +87,170 | ## Recent filings [All 793 filings](/companies/amwl/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-04 | 20:15 ET | [10-Q](/filings/0001393584-26-000018.md) | Quarterly report, period 2026-06-30 | 0001393584-26-000018 | | 2026-08-04 | 20:08 ET | [8-K](/filings/0001393584-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001393584-26-000016 | | 2026-07-21 | 21:33 ET | [8-K](/filings/0001193125-26-309112.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-309112 | | 2026-07-14 | 20:39 ET | [8-K](/filings/0001193125-26-303282.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-303282 | | 2026-06-22 | 20:40 ET | [8-K](/filings/0001193125-26-277605.md) | 5.07 Shareholder vote results | 0001193125-26-277605 | | 2026-05-12 | 12:44 ET | [8-K](/filings/0001193125-26-218277.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-218277 | | 2026-05-05 | 20:18 ET | [10-Q](/filings/0001393584-26-000013.md) | Quarterly report, period 2026-03-31 | 0001393584-26-000013 | | 2026-05-05 | 20:14 ET | [8-K](/filings/0001193125-26-206427.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206427 | | 2026-04-23 | 19:10 ET | [DEF 14A](/filings/0001393584-26-000008.md) | Proxy statement, period 2026-04-23 | 0001393584-26-000008 | | 2026-04-02 | 21:06 ET | [8-K](/filings/0001193125-26-140460.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-140460 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-048776.md), filed Feb 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/98cdbc9f-763f-45ff-a1d6-1921b06e7c3a) ## About the filer - CIK: 1393584 - Tickers: AMWL - Exchange: NYSE - SIC code: 7389 Services-Business Services, NEC - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.